Adacel/Adacel Polio

Adacel/Adacel Polio Indications/Uses

Manufacturer:

Sanofi

Distributor:

Zuellig
/
Four Star
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
ADACEL-POLIO is indicated for active booster immunization for the prevention of tetanus, diphtheria, pertussis (whooping cough) and poliomyelitis in persons 4 years of age and above.
In children 4 to 6 years of age, ADACEL-POLIO may be considered as an alternative for the fifth dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (DTaP-IPV).
Persons who have had tetanus, diphtheria or pertussis should still be immunized since these clinical infections do not always confer immunity. Human Immunodeficiency Virus (HIV)-infected persons, both asymptomatic and symptomatic, should be immunized against tetanus, diphtheria and pertussis according to standard schedules.
ADACEL-POLIO is not to be used for the treatment of disease caused by Bordetella pertussis, Corynebacterium diphtheriae, Clostridium tetani or poliomyelitis infections.
Pediatrics: ADACEL-POLIO has been used in clinical studies in children as young as 3 years of age.
Geriatrics: ADACEL-POLIO has been used in clinical studies in persons up to 91 years of age.
Tetanus Prophylaxis in Wound Management: The need for active immunization with a tetanus toxoid-containing preparation (such as Td Adsorbed vaccine, ADACEL or ADACEL-POLIO) with or without passive immunization with Tetanus Immune Globulin, depends on both the condition of the wound and the patient’s vaccination history. (See DOSAGE & ADMINISTRATION.)
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in